AU2978500A - Method for the prevention or reduction of cardiovascular events associated with coronary intervention - Google Patents
Method for the prevention or reduction of cardiovascular events associated with coronary intervention Download PDFInfo
- Publication number
- AU2978500A AU2978500A AU29785/00A AU2978500A AU2978500A AU 2978500 A AU2978500 A AU 2978500A AU 29785/00 A AU29785/00 A AU 29785/00A AU 2978500 A AU2978500 A AU 2978500A AU 2978500 A AU2978500 A AU 2978500A
- Authority
- AU
- Australia
- Prior art keywords
- coronary intervention
- pharmaceutically acceptable
- acceptable salt
- dosage
- dimethoxycinnamoyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11846399P | 1999-02-03 | 1999-02-03 | |
| US60118463 | 1999-02-03 | ||
| PCT/US2000/002611 WO2000045810A1 (en) | 1999-02-03 | 2000-02-02 | Method for the prevention or reduction of cardiovascular events associated with coronary intervention |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2978500A true AU2978500A (en) | 2000-08-25 |
Family
ID=22378760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU29785/00A Abandoned AU2978500A (en) | 1999-02-03 | 2000-02-02 | Method for the prevention or reduction of cardiovascular events associated with coronary intervention |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1180027A4 (es) |
| JP (1) | JP2002536326A (es) |
| KR (1) | KR20010101933A (es) |
| CN (1) | CN1338930A (es) |
| AR (1) | AR022475A1 (es) |
| AU (1) | AU2978500A (es) |
| BR (1) | BR0007901A (es) |
| CA (1) | CA2361578A1 (es) |
| CO (1) | CO5160246A1 (es) |
| HU (1) | HUP0200148A3 (es) |
| IL (1) | IL144719A0 (es) |
| MX (1) | MXPA01007833A (es) |
| NO (1) | NO20013789L (es) |
| PL (1) | PL349926A1 (es) |
| TR (1) | TR200102262T2 (es) |
| WO (1) | WO2000045810A1 (es) |
| ZA (1) | ZA200106297B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8097650B2 (en) * | 2005-07-27 | 2012-01-17 | The Trustees Of Columbia University In The City Of New York | Method of treating a condition associated with phosphorylation of TASK-1 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2617407B2 (ja) * | 1992-09-14 | 1997-06-04 | キッセイ薬品工業株式会社 | 血管内膜細胞過剰増殖疾患の予防および治療剤 |
| WO1997009301A1 (fr) * | 1995-09-07 | 1997-03-13 | Kissei Pharmaceutical Co., Ltd. | Derives de 2-acylaminobenzamide, preventif et remede contre des maladies causees par une surmultiplication des cellules vasculaires de l'intima |
| US6019104A (en) * | 1996-12-30 | 2000-02-01 | Kissei Pharmaceutical Co., Ltd. | Method for the treatment or prevention of restenosis associated with coronary intervention |
-
2000
- 2000-02-02 IL IL14471900A patent/IL144719A0/xx unknown
- 2000-02-02 CN CN00803386A patent/CN1338930A/zh active Pending
- 2000-02-02 KR KR1020017009743A patent/KR20010101933A/ko not_active Application Discontinuation
- 2000-02-02 HU HU0200148A patent/HUP0200148A3/hu unknown
- 2000-02-02 WO PCT/US2000/002611 patent/WO2000045810A1/en not_active Application Discontinuation
- 2000-02-02 AU AU29785/00A patent/AU2978500A/en not_active Abandoned
- 2000-02-02 CA CA002361578A patent/CA2361578A1/en not_active Abandoned
- 2000-02-02 AR ARP000100437A patent/AR022475A1/es unknown
- 2000-02-02 MX MXPA01007833A patent/MXPA01007833A/es unknown
- 2000-02-02 TR TR2001/02262T patent/TR200102262T2/xx unknown
- 2000-02-02 BR BR0007901-4A patent/BR0007901A/pt not_active Application Discontinuation
- 2000-02-02 EP EP00908440A patent/EP1180027A4/en not_active Withdrawn
- 2000-02-02 PL PL00349926A patent/PL349926A1/xx not_active Application Discontinuation
- 2000-02-02 JP JP2000596930A patent/JP2002536326A/ja not_active Withdrawn
- 2000-02-03 CO CO00006605A patent/CO5160246A1/es unknown
-
2001
- 2001-07-31 ZA ZA200106297A patent/ZA200106297B/en unknown
- 2001-08-02 NO NO20013789A patent/NO20013789L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1180027A4 (en) | 2004-11-17 |
| CO5160246A1 (es) | 2002-05-30 |
| HUP0200148A3 (en) | 2003-06-30 |
| PL349926A1 (en) | 2002-10-21 |
| NO20013789D0 (no) | 2001-08-02 |
| JP2002536326A (ja) | 2002-10-29 |
| WO2000045810A1 (en) | 2000-08-10 |
| AR022475A1 (es) | 2002-09-04 |
| MXPA01007833A (es) | 2002-06-21 |
| IL144719A0 (en) | 2002-06-30 |
| HUP0200148A2 (hu) | 2002-05-29 |
| ZA200106297B (en) | 2002-07-31 |
| KR20010101933A (ko) | 2001-11-15 |
| CN1338930A (zh) | 2002-03-06 |
| EP1180027A1 (en) | 2002-02-20 |
| NO20013789L (no) | 2001-09-28 |
| BR0007901A (pt) | 2001-10-30 |
| TR200102262T2 (tr) | 2002-02-21 |
| CA2361578A1 (en) | 2000-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2106172C (en) | Use of 2-(3,4-dimethoxycinnamoyl)aminobenzoic acid for the treatment of restenosis associated with coronary intervention | |
| TW389696B (en) | Accelerated release composition containing bromocriptine | |
| RU2221563C2 (ru) | Фармацевтическая композиция для лечения болезни паркинсона и синдромов паркинсона, способ ее получения, способ лечения болезни паркинсона и синдромов паркинсона | |
| KR19980064024A (ko) | 약학 조성물 | |
| HU217833B (hu) | Eljárás difenil-butil-piperazin-karboxamidokat tartalmazó, mértéktelen szerfogyasztásból eredő betegségek kezelésére alkalmas gyógyszerkészítmények előállítására | |
| JPS63104930A (ja) | 安定化薬剤組成物 | |
| WO2004066998A1 (ja) | 安定な経口用固形医薬組成物 | |
| JPH02223521A (ja) | 血清コレステロール低下剤 | |
| AU2978500A (en) | Method for the prevention or reduction of cardiovascular events associated with coronary intervention | |
| KR20070085508A (ko) | 지질 농후 플라크의 감소, 안정화 및 파열 방지 방법 | |
| WO2001062241A1 (en) | Method for the prevention or reduction of vascular access dysfunction | |
| AU2636600A (en) | Method for the prevention or reduction of cardiovascular events associated with coronary intervention | |
| JP3150642B2 (ja) | 新規な抗痙攣性及び抗炎症性組成物並びにそれらの製造方法 | |
| WO2001097798A1 (en) | Method for the prevention or reduction of cardiovascular events associated with coronary intervention | |
| WO2003043632A2 (en) | Use of bisindolmaleimide and gemcitabine for the treatment of cancer | |
| CA2566684C (en) | Pharmaceutical nitrones | |
| WO2019241495A1 (en) | Pharmaceutical composition and method for acute on chronic liver failure | |
| IE71022B1 (en) | Stabilizer for 4-ethyl-2-hydroxyimino-5-nitro-3-hexenamides containing preparation and stabilizing method therefor | |
| JPH0788300B2 (ja) | エピニンあるいはその製薬的に許容しうる塩を含む医薬組成物ならびに用途 | |
| US20080139668A1 (en) | Pharmaceutical composition for obovatol for the prevention and treatment of restenosis | |
| AU627277B2 (en) | A method of treatment or prevention of post-ptca restenosis by post-ptca restenosis inhibitor | |
| JPS61129124A (ja) | 抗腫瘍剤 | |
| WO2002056941A2 (en) | Method for the treatment of peripheral vascular disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |